The DOI matches its Crossref record.
Reciprocal Regulation of Neu Tyrosine Kinase Activity and Caveolin-1 Protein Expression in Vitro and in Vivo
Open accessAbstract
Neu (c-erbB2) is a proto-oncogene product that encodes an epidermal growth factor-like receptor tyrosine kinase. Amplification of wild-type c-Neu and mutational activation of Neu (Neu T) have been implicated in oncogenic transformation of cultured fibroblasts and mammary tumorigenesis in vivo. Here, we examine the relationship between Neu tyrosine kinase activity and caveolin-1 protein expression in vitro and in vivo. Recent studies have suggested that caveolins may function as negative regulators of signal transduction. Our current results show that mutational activation of c-Neu down-regulates caveolin-1 protein expression, but not caveolin-2, in cultured NIH 3T3 and Rat 1 cells. Conversely, recombinant overexpression of caveolin-1 blocks Neu-mediated signal transduction in vivo. These results suggest a reciprocal relationship between c-Neu tyrosine kinase activity and caveolin-1 protein expression. We next analyzed a variety of caveolin-1 deletion mutants to map this caveolin-1-dependent inhibitory activity to a given region of the caveolin-1 molecule. Results from this mutational analysis show that this functional in vivo inhibitory activity is contained within caveolin-1 residues 32-95. In accordance with these in vivo studies, a 20-amino acid peptide derived from this region (the caveolin-1 scaffolding domain) was sufficient to inhibit Neu autophosphorylation in an in vitro kinase assay. To further confirm or refute the relevance of our findings in vivo, we next examined the expression levels of caveolin-1 in mammary tumors derived from c-Neu transgenic mice. Our results indicate that dramatic reduction of caveolin-1 expression occurs in mammary tumors derived from c-Neu-expressing transgenic mice and other transgenic mice expressing downstream effectors of Neu-mediated signal transduction, such as Src and Ras. Taken together, our data suggest that a novel form of reciprocal negative regulation exists between c-Neu and caveolin-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Caveolin-1 Null Mice Are Viable but Show Evidence of Hyperproliferative and Vascular Abnormalities
Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105408200 · Cited by 1,158
Self-citationCaveolins, Liquid-Ordered Domains, and Signal Transduction
Smart, E. J., Graf, G. A., McNiven, M. A., Sessa, W. C., Engelman, J. A., Scherer, P. E., Okamoto, T., & Lisanti, M. P. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7289 · Cited by 1,006
Self-citationCaveolae: From Cell Biology to Animal Physiology
Razani, B., Woodman, S. E., & Lisanti, M. P. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.3.431 · Cited by 987
Self-citationRole of Caveolae and Caveolins in Health and Disease
Cohen, A. W., Hnasko, R., Schubert, W., & Lisanti, M. P. (2004) · Physiological Reviews · doi:10.1152/physrev.00046.2003 · Cited by 893
Self-citationRazani, B., Zhang, X. L., Bitzer, M., von Gersdorff, G., Böttinger, E. P., & Lisanti, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008340200 · Cited by 639
Self-citationMembrane microdomains and caveolae
Kurzchalia, T. V., & Partan, R. G. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80061-1 · Cited by 579
Zhuang, L., Kim, J., Adam, R. M., Solomon, K. R., & Freeman, M. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200519935 · Cited by 567
“On the other hand, Cav-1 is capable of suppressing the activity of a number of signaling proteins activated in aggressive cancers, including Src-like kinases (15) and certain receptor tyrosine kinases (16).”
BackgroundCaveolin-1 in oncogenic transformation, cancer, and metastasis
Williams, T. M., & Lisanti, M. P. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00458.2004 · Cited by 511
Self-citationGalbiati, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6633 · Cited by 471
Pickl, M., & Ries, C. H. (2009) · Oncogene · doi:10.1038/onc.2008.394 · Cited by 401
Signal transduction and oncogenesis by ErbB/HER receptors
Marmor, M. D., Skaria, K. B., & Yarden, Y. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.06.002 · Cited by 389
Spatial regulation of receptor tyrosine kinases in development and cancer
Casaletto, J. B., & McClatchey, A. I. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3277 · Cited by 359
Lee, H., Volonté, D., Galbiati, F., Iyengar, P., Lublin, D. M., Bregman, D. B., Wilson, M. T., Campos‐González, R., Bouzahzah, B., Pestell, R. G., et al. (2000) · Molecular Endocrinology · doi:10.1210/me.14.11.1750 · Cited by 327
Self-citationCaveolin-1 in tumor progression: the good, the bad and the ugly
Goetz, J. G., Lajoie, P., Wiseman, S. M., & Nabi, I. R. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9160-9 · Cited by 299
Regulation of signal transduction by endocytosis
Ceresa, B. P., & Schmid, S. L. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00077-0 · Cited by 294
Caveolin-1 and Cancer Metabolism in the Tumor Microenvironment: Markers, Models, and Mechanisms
Sotgia, F., Martinez-Outschoorn, U. E., Howell, A., Pestell, R. G., Pavlides, S., & Lisanti, M. P. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-120856 · Cited by 281
Self-citationWilliams, T. M., Medina, F., Badano, I., Hazan, R. B., Hutchinson, J., Muller, W. J., Chopra, N. G., Scherer, P. E., Pestell, R. G., & Lisanti, M. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409214200 · Cited by 280
Self-citationLabrecque, L., Royal, I., Surprenant, D. S., Patterson, C., Gingras, D., & Béliveau, R. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-07-0379 · Cited by 275
Wiechen, K., Diatchenko, L., Agoulnik, A., Scharff, K. M., Schober, H., Arlt, K., Zhumabayeva, B., Siebert, P. D., Dietel, M., Schäfer, R., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63010-6 · Cited by 275
Caveolae: mining little caves for new cancer targets
Carver, L. A., & Schnitzer, J. E. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1146 · Cited by 267
Fiucci, G., Ravid, D., Reich, R., & Liscovitch, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205300 · Cited by 262
Galbiati, F., Volonte', D., Liu, J., Capozza, F., Frank, P. G., Zhu, L., Pestell, R. G., & Lisanti, M. P. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.8.2229 · Cited by 259
Self-citationThe Biology of Caveolae: Lessons from Caveolin Knockout Mice and Implications for Human Disease
Hnasko, R. (2003) · Molecular Interventions · doi:10.1124/mi.3.8.445 · Cited by 253
Metadata
- Authors
- Engelman, J. A., Lee, R. J., Karnezis, A., Bearss, D. J., Webster, M., Siegel, P., Muller, W. J., Windle, J. J., Pestell, R. G., & Lisanti, M. P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-08
- Volume
- 273
- Issue
- 32
- Pages
- 20448-20455
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2094222567
- Cited by
- 209
- References
- 0
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.